Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation

Human Reproduction

Volumn 9, Issue 5, 1994, Pages 788-791

  Diedrich, K ^a   Diedrich, C ^a   Santos, E ^b   Zoll, C ^a   Al hasani, S ^a   Reissmann, T ^c   Krebs, D ^b   Klingmuller D ^d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c ASTA MEDICA AG   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

GnRH agonist; In vitro fertilization; LH surge; Ovulation induction

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INFERTILITY; LUTEINIZING HORMONE RELEASE; NEEDLE BIOPSY; OOCYTE; OVARY CELL; OVARY FOLLICLE MATURATION; OVULATION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSVAGINAL ECHOGRAPHY;

EID: 0028283353     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a138597     Document Type: Article

References (22)

1. Bajusz, S., Kovacs, M., Gazdag, M., Bokser, L., Karashima, T., Csernus, V. J., Janaky, T., Guoth, J. and Schally, A. V. (1988a) Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects. Proc. Natl. Acad. Sci. USA, 85, 1637-1641.
2. Bajusz, S., Csernus, V. J., Janaky, T., Bokser, L., Fekete, M. and Schally, A. V. (1988b). New antagonists of LHRH. Int, J. Peptide Res., 32, 425-435.
3. Behre, H. M., Klein, B., Steinmeyer, E., McGregor, G. P., Voigt, K. and Nieschlag, E. (1992) Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist Cetrorelix (SB-75) in normal men, J. Clin. Endocrinol. Metab., 75, 393-398.
4. Cohen, J. (1991) Outcome of IVF pregnancies in 1989. IV. World Congress of IVF, Paris.
5. Diedrich, K., van der Ven, H. and Krebs, H. (1985) Physiologie der Reproduktion: In Krebs, D. (Hersg.) Reproduktion-StOrung in der Friihgraviditat. Klinik Frauenheil. Geburtsh., 3, 5-83.
6. Diedrich, K. and Krebs, D. (1990) Indikation und Ergebnisse zur in vitro Fertilisation (TVF), intratubarem Gameten-Gift) und Embryotransfer (ETFT). OynOkolo., 23, 186-195.
7. Diedrich, K., Al-Hasani, S., van der Ven, H., Bauer, O., Werner, A. and Krebs, D. (1992) Indications for in-vitro fertilization and results. Hum. Reprod., 7, 115-121.
8. Ditkoff, E. C. et al. (1991) The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am, J. Obstet. Oynecol., 165, 1811-1817.
9. Fleming, R. and Coutts, J. R. T. (1986) Induction of multiple follicular growth in normally menstruating women with endogenous gonadotrophin suppression. Fertil. Steril., 45, 226-230.
10. Frazer, H. M. and Sandow, J. (1985) Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the last luteal phase in the stumptailed macaque monkey, J. Clin. Endocrinol. Metab., 60, 570-584.
11. Gonzalez-Barcena, D., Vadillo-Buenfil, M., Guerra-Arguero, E., Carenno, J., Comaru-Schally, A. M. and Schally, A. V. (1990) Potent antagonistic analog of LH-RH (SB-75) inhibits LH, FSH and testosterone levels in human beings. The Endocrine Society Meeting, Atlanta, Ga, Abstract no. 1318, p. 354.
12. Klingmuller, D., Diedrich, K. and Sommer, L. (1993) Effects of the GnRH antagonist CETRORELIX in normal women. Oynecol. Endocrinol., 7, 2-8.
13. Knobil, E. (1980) The neuroendocrine control of the menstrual cycle. Recent Prog. Horn. Res., 36, 53-58.
14. Loumaye, E. (1990) The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum. Reprod., 5, 357-376.
15. Pavlou, S. N. (1987) Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men, J. Clin. Endocrinol. Metab., 64, 1070-1075.
16. Reissmann, T., Hilgard, P., Harlemans, H., Engel, J., Schally, A. V. and Comaru-Schally, A. M. (1992) Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone, J. Cancer Res. Clin. Oncol., 118, 44-49.
17. Schally, A. V., Gonzalez-Barcena, D. and Reissmann, T. (1990) New antagonistic analogs of LH-RH: experimental oncological and clinical studies. International Symposium on GnRH Analogues in Cancer and Human Reproduction; Geneva, November 6-10, 1990. Oynecol. Endocrinol., 4, 92.
18. Schmutzler, R. K. and Diedrich, K. (1990) Basic and clinical aspects of GnRH-agonists in reproduction. Int, J. Oynecol. Obstet., 32, 311-324.
19. Smhz, J., Ron-El, R. and Tarlatzis, B. C. (1992) The use of gonadotrophin releasing hormone agonists for in-vitro fertilization and other assisted procreation techniques: experience from three centres. Hum. Reprod., 7, 49-66.
20. Stanger, J. D. and Yovich, J. L. (1985) Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br, J. Obstet. Gynaecol., 92, 385-393.
21. Weinbauer, G. F. and Nieschlag, E. (1990) Evaluation of the antigonadotrophic activity of different GnRH antagonist in the non human primate. Oynecol. Endocrinol., 4, 21.
22. Wildt, L., Diedrich, K., van der Ven, H., Al-Hasani, S., Hubner, S. and Klasen, R. (1986) Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum. Reprod., 1, 15.